Symmune Therapeutics, LLC — Form D

Symmune Therapeutics, LLC of DURHAM, NC, a company, filed a Form D exempt-offering notice with the SEC on 2018-08-09. The offering totals $300K, of which $125K was reported sold. Industry: Biotechnology.

Offering

• Filed: 2018-08-09
• Form: D
• Accession: 0001749423-18-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $300K
• Amount sold: $125K
• Remaining: $175K
• Investors: 5
• Date of first sale: 2018-07-30
• Security types: debt
• Revenue range: Decline to Disclose
• SEC file number: 021-318830

Issuer

• Name: Symmune Therapeutics, LLC
• CIK: 0001749423
• Entity type: Limited Liability Company
• Jurisdiction: DELAWARE
• Incorporated: 2015
• Address: 201 West Main Street, DURHAM, NC, 27701
• Phone: 650-823-1706

Officers, directors & promoters (3)

More

• CIK 1749423 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search